Recolony AG’s Post

Congratulations to Reimagine Care for being named one of 16 startups companies to be included in CancerX Moonshot's inaugural Accelerator cohort! The Accelerator aims to provide promising startups with a roadmap to successfully scale their companies upon completion of the 4-month program. Kristen Honey, Chief Data Scientist and Executive Director of Team InnovationX under the U.S. Department of Health & Human Services, expressed her excitement at the announcement, stating, "The public-private partnership model allows us to lean on the complementary expertise of government agencies, coupled with industry leaders in digital innovation and oncology, to identify promising new innovations, nurture them, and put together the right pieces to convert it into real change for the people impacted by cancer." Read the full article at the link below. #ReimagineCare #Oncology #Cancer #Healthcare #Medical #News

Outside of paywall: Below is a round-up of seven innovative start-up leaders who shared their story with me HLTH USA this week. More coverage to come Citeline's Medtech Insight. #medtech #innovation #startups #funding #FDA #AI #digitalhealth

Hey #Brilliantly Community! 🚀 Let's take a deep dive into the captivating world of entrepreneurship with Kristen's remarkable journey through Techstars in Fort Worth! 🌟 Imagine the scene: a determined entrepreneur, armed with nothing but an idea and a drive to succeed, enters the high-energy environment of Techstars. Kristen's story embodies this spirit of fearless #innovation and relentless pursuit of excellence. As the article vividly portrays, Kristen's time with Techstars was nothing short of a rollercoaster ride. From late nights brainstorming to early mornings hustling, she embraced every challenge with grace and tenacity. Through the ups and downs, she stayed true to her vision, learning, growing, and adapting along the way. 🎢 But Kristen's journey wasn't just about building a business; it was about building a community. She fostered relationships, collaborated with peers, and sought mentorship from industry experts. Her ability to connect and inspire is a testament to the power of community in the entrepreneurial landscape. Now, as we read about Kristen's accomplishments and milestones, we can't help but feel inspired. Her story reminds us that success is not just about the destination; it's about the journey—the lessons learned, the hurdles overcome, and the relationships forged. 🧡 So, here's to Kristen and all the aspiring entrepreneurs out there. May your path be filled with challenges that make you stronger, opportunities that fuel your passion, and moments that define your legacy. Keep dreaming, keep innovating, and keep shining bright! ✨ Check out Kristen's full story here: https://lnkd.in/e46qwUsQ. Kristen, you're a true inspiration to us all! #Techstars #Entrepreneurship #Innovation #Inspiration #BeBrilliantlyBeYou #TechstarsFortWorth #InternationalWomensMonth #IWM2024 #FemTech #WearableTech

We want to hear from you!! Tell us what you want to know about #biotech and #medtech #innovation Cincinnati Children's? If you want to stay up-to-date with us, follow our Page. #techtransfer #startups #venturecapital

Research Institution Proof of Concept, Startup Accelerator, and Venture Fund Gap Fund and Accelerator Programs (GAP for short) #innovation #university #research #gapfunding #proofofconcept #startup #accelerator #venture #commercialization

From AllTopStartups: Results from Anavex Life Sciences’ Landmark Trial Presented at Alzheimer’s Association Conference ------------------------------- Anavex Life Sciences recently presented comprehensive results from a Phase IIb/III study showing that its compound blarcamesine, or Anavex 2-73, significantly slowed clinical decline in people with early Alzheimer’s disease.… The post Results from Anavex Life Sciences’ Landmark Trial Presented at Alzheimer’s Association Conference appeared first on AllTopStartups . #entrepreneur #startups #learnbusiness #techstartups #marketingtips #emailmarketing #businesstools #marketingstrategy #businessowner #startupbusiness #startuplife

Venture Kick startup Lymphatica Medtech closes EUR 17.9 million funding round to drive Innovation in Lymphedema Treatment. Congratulations to team of founders Marco Pisano (CEO) and Valentina Triacca (CCO) with their great team! https://lnkd.in/g3vxb34i About: Lymphatica, a medical device company, has raised EUR 17.9 million in Series B funding to accelerate the development and validation of LymphoDrain, the first implantable system for treating chronic lymphedema. Lymphedema, a common side effect of cancer therapies, causes limb swelling, pain, and recurrent infections, impacting over 10 million people in Europe and the U.S. This investment will advance Lymphatica's breakthrough technology, which aims to locally replace the lymphatic drainage function, offering unprecedented benefits to patients and healthcare professionals, and improving the lives of millions worldwide. #VentureKick #MedTech #SwissStartups 

Congrats to Brandon Li and the Power team on their Series A! Excited to be a part of the journey. Here is why Caila Pickett and I got so excited about what they're building – THE consumer marketplace for clinical trials. Current State... 🏥 Over 85% of all clinical trials are delayed due to an inability to recruit enough patients 💉 Patient recruitment is the # 1 reason why research fails 👩⚕️ Enrollment disproportionately impacts women, people of color. and other populations that historically have been excluded from medical research 👨⚕️ Clinical trial recruitment is at an inflection point. Over the past 15 years, the industry has undergone major transformations, creating an environment ripe for innovation, capitalizing on the shift towards patient centricity, wherein patients are truly seen as the ultimate users in clinical research With Power... 📈 Power solves Pharma’s biggest R&D problem – patient recruitment, making it easier for patients to find clinical trial opportunities ⚕ Patients can more easily (1) Discover leading medical researchers with Power's modern search UX and nlp-powered filters (2) Evaluate options using safety and efficacy data, reviews, and researcher testimonials and (3) Match with verified researchers ⏹ Broader participation in clinical research improves scientific understanding of how different demographic groups respond to new treatments and ultimately improve treatment options for people in traditionally underrepresented groups

#fundingalert 💼Company: Vandria SA 💰Funding: $30.7Million ⚡Round: Series A 👥Investors: Hevolution Foundation, Dolby Family Ventures, ND Capital Vandria is at the vanguard of #mitochondrial therapeutics. It is developing first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. Its lead program, VNA-318 is a brain-penetrant, patent-protected, mitophagy inducer which has been shown to acutely improve memory and learning and to have strong disease-modifying effects in models of neurodegenerative disease such as Alzheimer’s and Parkinson’s disease. Klaus Dugi, Sourav Kole, Jens Eckstein, Pénélope Andreux   Read more - https://lnkd.in/g4stGm89 To share your startup story write us on - contact@startuprise.co.uk #Vandria #NDCapital #Medtech #neurodegenerative #News #Fundraising #Funding #startup #Europeanstartup

🚨 A good reminder to all my MedTech and Digital Health startup colleagues and clients. This is a big deal, showing that you are doing your due diligence to avoid bias will be something more and more VC's will want to see before investing future $$$. https://lnkd.in/gsGHwYtu